Skip to content
    Target Global logo

    Target Global

    London, United KingdomFounded 2015

    Target Global is a pan-European venture capital firm with offices in London, Berlin, Tel Aviv, and Abu Dhabi. Its latest vehicle, Early Stage Fund III, closed in January 2022 at $214 million to lead and co-lead seed and Series A rounds; across all funds the firm manages over €3 billion in total assets.

    Deal activity decreased year-over-year (1 deal in the last 12 months vs 5 prior). Average disclosed round size is $52.4M (across 142 rounds with reported amounts).

    Find people at Target Global on Goldilocks AI

    Portfolio

    131

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    1

    Team

    PR

    Peter Roos

    Partner and CFO

    MH

    Manu H.

    Investor

    MF

    Martina Facchin

    Investing

    AS

    Alexander Sevenyuk

    VC

    AS

    Arthur Sultanov

    VC

    DB

    Dana Bublil

    VC

    ML

    Mike Lobanov

    Founder&GP

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    195 investments
    CompanyRoundAmountDate
    Nimble logoNimbleSeries B$47MFeb 2026
    Finom logoFinomGrowth—May 2025
    Alta logoAltaSeed$7MMar 2025
    Voyantis logoVoyantisSeries B$41MFeb 2025
    Perk logoPerkSeries E—Jan 2025
    PALM logoPALMSeed$6.1MSep 2024
    MMagnus MetalSeries B$74MApr 2024
    MMagnusSeries B$74MApr 2024
    Robovision logoRobovisionSeries A—Mar 2024
    AQUATY logoAQUATYPre-Seed—Mar 2024
    Finom logoFinomSeries B$54MFeb 2024
    Saleor logoSaleorSeed$8MFeb 2024
    Flo Health logoFlo HealthSeries B$50MJan 2024
    Tourlane logoTourlaneSeries D$25MJan 2024
    Robovision logoRobovisionUnknown$42MJan 2024
    Crisp logoCrispSeries A—Nov 2023
    Lepaya logoLepayaGrowth—Sep 2023
    Communion logoCommunionPre-Seed—Aug 2023
    AAtlySeries A$16.8MMay 2023
    Patient21 logoPatient21Series C$66MMay 2023
    Enter logoEnterSeries A$21MApr 2023
    Theva logoThevaSeries D—Jan 2023
    Patient21 logoPatient21Series C$108MJan 2023
    wefox Group logowefox GroupSeries D$110MJan 2023
    Cobee logoCobeeSeries B$41MNov 2022
    Page 1 of 8

    Top Co-Investors

    Last updated: 27 September 2026